Moreover, the results were corroborated by immunofluorescence staining, which demonstrated a statistically significant reduction in the expression levels of NDEL1, DYNEIN, and TUBA1A in the tumor tissues obtained from miR-134-3p-treated HuOCSCs compared with those derived from miR-mut-transfected HuOCSCs (Figure 3G, Supplementary data Figure S2). The gene discussed is TUBA1A; the disease is neoplasm.